Prolactinoma pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Prolactinoma}}
{{Prolactinoma}}
{{CMG}} {{AE}}{{Faizan}}
{{CMG}} {{AE}}{{Anmol}}
 
==Overview==
==Overview==
[[Prolactinoma]] may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1). A minority of prolactinomas are associated with [[Carney complex]], [[McCune-Albright Syndrome]], MEN like syndrome (''CKDN1B'' loss of function).<ref name="Radiopedia">http://radiopaedia.org/articles/pituitary-adenoma</ref>
Prolactinoma is the most common type of Pituitary adenomas. Prolactinomas may occur in approximately 30% of Multiple endocrine neoplasia type 1.It may also occur with Carney complex or McCune-Albright syndrome. There are a few reports of familial cases of prolactinoma unrelated to MEN 1 syndrome.<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062  }} </ref>


==Pathophysiology==
==Pathophysiology==
*Most of prolactinomas are related to multiple endocrine neoplasia type 1.<ref name="pmid15153434">{{cite journal| author=Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB et al.| title=Molecular pathology of the MEN1 gene. | journal=Ann N Y Acad Sci | year= 2004 | volume= 1014 | issue=  | pages= 189-98 | pmid=15153434 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15153434  }} </ref>
** MEN1 gene is located on 11q13.
** MEN1 is a tumor suppressor gene which follows the 'two-hit hypothesis' which implies that both alleles that code for a particular gene must be affected before an effect is manifested.
**This is due to the fact that if only one allele for the gene is damaged, the second can still produce the correct protein.
**Affected individuals carries one altered copy of MEN1 gene and the other copy is lost due to somatic mutation.


==Associated Diseases==
==Associated Diseases==
[[Prolactinoma]] may occur as part of a hereditary disorder called [[multiple endocrine neoplasia type 1]] (MEN 1). A minority of prolactinomas are associated with:<ref name="Radiopedia">http://radiopaedia.org/articles/pituitary-adenoma</ref>
[[Prolactinoma]] may occur as part of a hereditary disorder called [[multiple endocrine neoplasia type 1]] (MEN 1). A minority of prolactinomas are associated with:<ref name="pmid16411062">{{cite journal| author=Ciccarelli A, Daly AF, Beckers A| title=The epidemiology of prolactinomas. | journal=Pituitary | year= 2005 | volume= 8 | issue= 1 | pages= 3-6 | pmid=16411062 | doi=10.1007/s11102-005-5079-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16411062  }} </ref>
*[[Multiple endocrine neoplasia type I]] ([[Multiple endocrine neoplasia type 1|MEN I]])
*[[Carney complex]]
*[[Carney complex]]
*[[McCune-Albright Syndrome]]
*[[McCune-Albright Syndrome]]
*MEN like syndrome (''CKDN1B'' loss of function)
 
====Familial pituitary adenomas====
====Familial pituitary adenomas====
A pituitary adenoma may be part of a familial syndrome:<ref name="pmid19564887">{{Cite journal | last1 = Elston | first1 = MS. | last2 = McDonald | first2 = KL. | last3 = Clifton-Bligh | first3 = RJ. | last4 = Robinson | first4 = BG. | title = Familial pituitary tumor syndromes. | journal = Nat Rev Endocrinol | volume = 5 | issue = 8 | pages = 453-61 | month = Aug | year = 2009 | doi = 10.1038/nrendo.2009.126 | PMID = 19564887 }}</ref>
A pituitary adenoma may be part of a familial syndrome:<ref name="pmid17613551">{{cite journal| author=Karhu A, Aaltonen LA| title=Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update. | journal=Hum Mol Genet | year= 2007 | volume= 16 Spec No 1 | issue= | pages= R73-9 | pmid=17613551 | doi=10.1093/hmg/ddm036 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17613551  }} </ref>
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
! Syndrome
! Syndrome
! Gene
! Gene
! Gene locus
! Notes
! Notes
|-
|-
| [[Multiple endocrine neoplasia type 1|Multiple endocrine neoplasia I]]
| [[Multiple endocrine neoplasia type 1|Multiple endocrine neoplasia I]]
| ''MEN1''
| ''MEN1''
| 11q13
| characterized by the 3 Ps: '''p'''ituitary adenoma, [[parathyroid adenoma|'''p'''arathyroid adenoma]], '''p'''ancreatic neuroendocrine tumor
| characterized by the 3 Ps: '''p'''ituitary adenoma, [[parathyroid adenoma|'''p'''arathyroid adenoma]], '''p'''ancreatic neuroendocrine tumor
|-
|-
| MEN-1-like syndrome
| MEN1-like syndrome
| ''CDKN1B''<ref name="omim600778">{{OMIM|600778}}</ref>
| ''CDKN1B''
| also known as ''Multiple endocrine neoplasia IV''<ref name="omim600778">{{OMIM|600778}}</ref>
| 12q13
| Associated with pituitary adenoma, parathyroid adenoma, neuroendocrine tumor
|-
|-
| [[Carney syndrome]]
| [[Carney complex]]
| ''PRKAR1A''
| ''PRKAR1A''
| 17q24
| other findings (mnemonic ''NAME''): nevi, [[atrial myxoma]], myxoid neurofibroma, ephelides (freckles)
| other findings (mnemonic ''NAME''): nevi, [[atrial myxoma]], myxoid neurofibroma, ephelides (freckles)
|-
|-
| Isolated [[pituitary adenoma]]<ref name="pmid22612670">{{Cite journal  | last1 = Korbonits | first1 = M. | last2 = Storr | first2 = H. | last3 = Kumar | first3 = AV. | title = Familial pituitary adenomas - Who should be tested for AIP mutations? | journal = Clin Endocrinol (Oxf) | volume =  | issue =  | pages =  | month = May | year = 2012 | doi = 10.1111/j.1365-2265.2012.04445.x | PMID = 22612670 }}</ref>
| Familial isolated pituitary adenoma
| ''AIP''
| ''AIP''
| classically growth hormone-producing adenoma - leads to [[acromegaly]]
| 11q13
|
*classically growth hormone-producing adenoma - leads to [[acromegaly]]
*may also be associated with prolactinomas.<ref name="pmid22612670">{{cite journal| author=Korbonits M, Storr H, Kumar AV| title=Familial pituitary adenomas - who should be tested for AIP mutations? | journal=Clin Endocrinol (Oxf) | year= 2012 | volume= 77 | issue= 3 | pages= 351-6 | pmid=22612670 | doi=10.1111/j.1365-2265.2012.04445.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22612670  }} </ref>
|}
|}
===Microscopic Pathology===
 
Features of prolactinoma include:
==Gross Pathology.<ref name=>{{cite book | last = Bigner | first = D. D. | title = Russell and Rubinstein's pathology of tumors of the nervous system | publisher = Hodder Arnold Distributed in the United States of America by Oxford University Press | location = London New York, NY | year = 2006 | isbn = 978-0340810071 }}</ref>==
*Loss of [[fibrous]] stroma
*Microprolactinoma (<10mm size) are usually found in the lateral wing of pituitary gland. They are most often surrounded by well defined pseudocapsule composed of reticulin.
*Normal (anterior) [[pituitary]] cells are nested
*Macroprolactinoma (>10mm size) differ substantially in size and behavior. Some causes sellar expansion while others invade the skull base.
Notes:
*About 50% of all prolactinoma grossly invade surrounding structure.
*Smears very well
 
===Stains===
==Microscopic Pathology==
*[[Reticulin]] - loss of reticulin between tumor cells
*Prolactinoma are of two types based on microscopy:
# sparsely granulated variant
# densely granulated variant
 


== References ==
== References ==

Revision as of 17:58, 19 July 2017

Prolactinoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Prolactinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

ECG

X-ray

Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Prolactinoma pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Prolactinoma pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Prolactinoma pathophysiology

CDC on Prolactinoma pathophysiology

Prolactinoma pathophysiology in the news

Blogs on Prolactinoma pathophysiology

Directions to Hospitals Treating Prolactinoma

Risk calculators and risk factors for Prolactinoma pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]

Overview

Prolactinoma is the most common type of Pituitary adenomas. Prolactinomas may occur in approximately 30% of Multiple endocrine neoplasia type 1.It may also occur with Carney complex or McCune-Albright syndrome. There are a few reports of familial cases of prolactinoma unrelated to MEN 1 syndrome.[1]

Pathophysiology

  • Most of prolactinomas are related to multiple endocrine neoplasia type 1.[2]
    • MEN1 gene is located on 11q13.
    • MEN1 is a tumor suppressor gene which follows the 'two-hit hypothesis' which implies that both alleles that code for a particular gene must be affected before an effect is manifested.
    • This is due to the fact that if only one allele for the gene is damaged, the second can still produce the correct protein.
    • Affected individuals carries one altered copy of MEN1 gene and the other copy is lost due to somatic mutation.


Associated Diseases

Prolactinoma may occur as part of a hereditary disorder called multiple endocrine neoplasia type 1 (MEN 1). A minority of prolactinomas are associated with:[1]

Familial pituitary adenomas

A pituitary adenoma may be part of a familial syndrome:[3]

Syndrome Gene Gene locus Notes
Multiple endocrine neoplasia I MEN1 11q13 characterized by the 3 Ps: pituitary adenoma, parathyroid adenoma, pancreatic neuroendocrine tumor
MEN1-like syndrome CDKN1B 12q13 Associated with pituitary adenoma, parathyroid adenoma, neuroendocrine tumor
Carney complex PRKAR1A 17q24 other findings (mnemonic NAME): nevi, atrial myxoma, myxoid neurofibroma, ephelides (freckles)
Familial isolated pituitary adenoma AIP 11q13
  • classically growth hormone-producing adenoma - leads to acromegaly
  • may also be associated with prolactinomas.[4]

Gross Pathology.[5]

  • Microprolactinoma (<10mm size) are usually found in the lateral wing of pituitary gland. They are most often surrounded by well defined pseudocapsule composed of reticulin.
  • Macroprolactinoma (>10mm size) differ substantially in size and behavior. Some causes sellar expansion while others invade the skull base.
  • About 50% of all prolactinoma grossly invade surrounding structure.

Microscopic Pathology

  • Prolactinoma are of two types based on microscopy:
  1. sparsely granulated variant
  2. densely granulated variant


References

  1. 1.0 1.1 Ciccarelli A, Daly AF, Beckers A (2005). "The epidemiology of prolactinomas". Pituitary. 8 (1): 3–6. doi:10.1007/s11102-005-5079-0. PMID 16411062.
  2. Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB; et al. (2004). "Molecular pathology of the MEN1 gene". Ann N Y Acad Sci. 1014: 189–98. PMID 15153434.
  3. Karhu A, Aaltonen LA (2007). "Susceptibility to pituitary neoplasia related to MEN-1, CDKN1B and AIP mutations: an update". Hum Mol Genet. 16 Spec No 1: R73–9. doi:10.1093/hmg/ddm036. PMID 17613551.
  4. Korbonits M, Storr H, Kumar AV (2012). "Familial pituitary adenomas - who should be tested for AIP mutations?". Clin Endocrinol (Oxf). 77 (3): 351–6. doi:10.1111/j.1365-2265.2012.04445.x. PMID 22612670.
  5. Bigner, D. D. (2006). Russell and Rubinstein's pathology of tumors of the nervous system. London New York, NY: Hodder Arnold Distributed in the United States of America by Oxford University Press. ISBN 978-0340810071.

Template:WikiDoc Sources